Literature DB >> 27491475

The association between multiple sclerosis and uveitis.

Tine Gadegaard Olsen1, Jette Frederiksen2.   

Abstract

The association between multiple sclerosis (MS) and uveitis has been questioned. Nerve tissue and eye tissue develop from the same embryonic cells; thus, MS and uveitis could be etiologically associated. In published studies, the prevalence of MS in patients with uveitis differe from 0.7% to 30.4%, whereas the prevalence of uveitis in patients with MS differe from 0.65% to 36.7%. Based on the largest retrospective studies, the prevalence of uveitis among MS patients is ∼1%, and the prevalence of MS among patients with uveitis is ∼1%. This is considerably higher than in the general population; thus, more research on this topic is needed to further understand the relationship between MS and uveitis. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  autoimmune disease; multiple sclerosis; neurology; ophthalmology; systematic review; uveitis

Mesh:

Year:  2016        PMID: 27491475     DOI: 10.1016/j.survophthal.2016.07.002

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  14 in total

Review 1.  Neurological Complications of Therapeutic Monoclonal Antibodies: Trends from Oncology to Rheumatology.

Authors:  Chandler Gill; Stasia Rouse; Ryan D Jacobson
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-17       Impact factor: 5.081

2.  [Intraocular inflammation in multiple sclerosis].

Authors:  N Stübiger; K Ruprecht; U Pleyer
Journal:  Ophthalmologe       Date:  2018-06       Impact factor: 1.059

3.  Uveitis prior to clinical presentation of Multiple Sclerosis (MS) is associated with better MS prognosis.

Authors:  Eyal Raskin; Anat Achiron; Ofira Zloto; Ron Neuman; Vicktoria Vishnevskia-Dai
Journal:  PLoS One       Date:  2022-06-29       Impact factor: 3.752

Review 4.  A Comprehensive Update on Retinal Vasculitis: Etiologies, Manifestations and Treatments.

Authors:  Aniruddha Agarwal; Anne Rübsam; Lynn Zur Bonsen; Francesco Pichi; Piergiorgio Neri; Uwe Pleyer
Journal:  J Clin Med       Date:  2022-04-30       Impact factor: 4.964

5.  Bilateral Anterior and Intermediate Uveitis with Occlusive Vasculitis as Sole Manifestation of Relapse in Multiple Sclerosis.

Authors:  Angelica Pedraza-Concha; Karin Brandauer; Alejandro Tello; Carlos Mario Rangel; Christian Scheib
Journal:  Case Rep Ophthalmol Med       Date:  2019-07-22

6.  Uveitis and Multiple Sclerosis: Potential Common Causal Mutations.

Authors:  Alejandra de-la-Torre; Claudia T Silva-Aldana; Juliana Muñoz-Ortiz; Laura B Piñeros-Hernández; Oscar Otero; Alejandra Domínguez; León A Faciolince; Mauricio Arcos-Holzinger; Claudio Mastronardi; Nora Constanza Contreras-Bravo; Carlos Martín Restrepo; Mauricio Arcos-Burgos
Journal:  Mol Neurobiol       Date:  2019-06-03       Impact factor: 5.590

7.  Objective quantification of vitreous haze on optical coherence tomography scans: no evidence for relationship between uveitis and inflammation in multiple sclerosis.

Authors:  D Coric; G Ometto; G Montesano; P A Keane; L J Balk; B M J Uitdehaag; A Petzold; D P Crabb; A K Denniston
Journal:  Eur J Neurol       Date:  2019-08-18       Impact factor: 6.089

8.  Uveitis, retinal vasculitis, and loss of accommodation as sole manifestations of demyelinating disease: A case report.

Authors:  Kalpana Babu; Gowri J Murthy; Krishna R Murthy
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

9.  AAV Mediated Delivery of Myxoma Virus M013 Gene Protects the Retina against Autoimmune Uveitis.

Authors:  Raela B Ridley; Brianna M Young; Jieun Lee; Erin Walsh; Chulbul M Ahmed; Alfred S Lewin; Cristhian J Ildefonso
Journal:  J Clin Med       Date:  2019-11-29       Impact factor: 4.241

Review 10.  Intermediate uveitis associated with MS: Diagnosis, clinical features, pathogenic mechanisms, and recommendations for management.

Authors:  Alan Abraham; Lindsay Nicholson; Andrew Dick; Claire Rice; Denize Atan
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.